Global Intravascular Catheters Market - 2023-2030

Global Intravascular Catheters Market - 2023-2030

Market Overview

The global intravascular catheters market reached US$ XX million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of xx% during the forecast period (2023-2030).

The Intravascular catheter is a thin, flexible tube inserted through a small incision in the skin into the renal pelvis of the kidney. The catheter is secured with a stitch or adhesive tape and connected to a drainage bag, which collects the urine. Intravascular catheters may be used for short-term or long-term kidney drainage, depending on the patient's medical condition.

Market Dynamics

The growing older population worldwide

Globally, people are living longer. Today, the majority of people may anticipate living into their 60s and beyond. The number of older people and their share of the population is increasing in every nation worldwide. Based on WHO data one in six individuals on the planet will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons in the globe who are 60 years or older will double by 2050. (2.1 billion). Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. As the geriatric population continues to grow, the use of IV catheters is becoming increasingly important in the care of older adults. IV catheters are commonly used in geriatric patients to provide access to the bloodstream for the delivery of medications, fluids, and nutrition.

Alternative available for intravenous catheters

Intravenous catheters are an important tool in modern medicine, there are several alternatives available that can be used for similar purposes. These alternatives include oral medications, intramuscular injections, and subcutaneous injections. This can limit the demand for IV catheters, particularly in cases where these alternatives are effective. The cost of IV catheters can be a limiting factor for their use, particularly in resource-limited settings. IV catheters can be relatively expensive, and the cost can increase if complications or infections arise.

COVID-19 Impact Analysis

The COVID-19 pandemic had a considerable impact on the intravascular catheter market. On the one hand, the increased demand for medical devices and supplies during the pandemic has led to a surge in demand for intravascular catheters in certain regions. As the pandemic has spread, there has been a surge in demand for critical care services, including the use of intravascular catheters for patients who require intensive care. This has led to increased demand for catheters in certain regions, particularly those that have been hit hardest by the pandemic. To reduce the spread of COVID-19, many healthcare providers have postponed non-essential medical procedures, including the placement of intravascular catheters for elective procedures.

Segment Analysis

The global intravascular catheter market is segmented based on product, application, and region.

Owing to their versatility, the oncology product

Intravascular catheters are commonly used in oncology for the administration of chemotherapy, as well as for the collection of blood samples for monitoring treatment efficacy and disease progression. Peripherally Inserted Central Catheters (PICCs) are another type of intravascular catheter that is commonly used in oncology. These catheters are typically inserted through a peripheral vein in the arm and are threaded through to the superior vena cava. PICCs provide a less invasive alternative to CVCs and can be used for the administration of chemotherapy drugs, as well as for the collection of blood samples.

Geographical Analysis

The growing demand for healthcare services and the increasing geriatric population

Asia Pacific region has emerged as the dominant market for intravascular catheters in recent years. This can be attributed to several factors, including the growing demand for healthcare services, the increasing prevalence of chronic diseases, and the expanding geriatric population. As healthcare systems in the Asia Pacific region continue to expand and modernize, there has been a growing demand for medical devices and supplies, including intravascular catheters. The Asia Pacific region has witnessed a rapid rise in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer. This has led to an increased demand for intravascular catheters for the administration of medication and other treatments.

Competitive Landscape

The major global players in the market include Omron Corporation, Koninklijke Philips N.V, Cook Medical, Allied Healthcare Products, Inc, Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Boston Scientific Corporation, Johnson & Johnson, GF Health Products, Inc.

Why Purchase the Report?

• To visualize the global Intravascular Catheters market segmentation based on product, application, end user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous Intravascular Catheters market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global intravascular catheters market report would provide approximately 61 tables, 58 figures, and 195+ Pages

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number Of Kidney Failures
4.1.1.2. Increasing Prevalence Of Chronic Diseases
4.1.1.3. XX
4.1.2. Restraints
4.1.2.1. The risk of Morbidity and Mortality Presented by Intravascular Catheters
4.1.2.2. XX
4.1.3. Opportunity
4.1.3.1. XX
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Short PIVC*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Integrated/Closed PIVC
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Oncology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gastroenterology
8.4. Renal Disease
8.5. Infectious Diseases
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Russia
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Omron Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Koninklijke Philips N.V
12.3. Cook Medical
12.4. Allied Healthcare Products, Inc
12.5. Becton, Dickinson, and Company
12.6. Agilent Technologies
12.7. Medline Industries, Inc.
12.8. Boston Scientific Corporation
12.9. Johnson & Johnson
12.10. GF Health Products, Inc
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings